Updated:
Prettybrook Partners
Prettybrook Partners focuses on management buyouts of public company divisions and investments in medical technology, healthcare services, and information...
Prettybrook Partners
Prettybrook Partners focuses on management buyouts of public company divisions and investments in medical technology, healthcare services, and information technology companies. The firm has made 18 investments, including a recent investment in G-Therapeutics.
General information
Firm type
Private Equity
Year founded
2012
Location
Region
North America
Country
United States
City
Austin
Corporate office
Austin, TX, United States
Frequently asked questions
Does Prettybrook Partners report its assets under management?
No. Prettybrook Partners does not publicly disclose assets under management, total capital deployed, or any fund vintages. The firm's AUM is treated as undisclosed. Without regulatory filings or limited-partner disclosures, the scale of its capital base cannot be independently verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: